Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1975-09-04
1977-05-17
Torrence, Dolph H.
Drug, bio-affecting and body treating compositions
Lymphokine
2601125R, 424177, 424180, 536 28, A61K 3700, A61K 4502, A61K 4504
Patent
active
040242412
ABSTRACT:
A nuclease-resistant hydrophilic complex of polyriboinosinic-polyribocytidylic acid, poly-l-lysine and carboxymethylcellulose, and injectable preparations thereof in a pharmaceutically acceptable aqueous carrier such as saline solution. When administered to a primate host, the complex is effective in inducing the synthesis in such host of antiviral levels of interferon.
REFERENCES:
patent: 2851453 (1958-09-01), Kennon
patent: 3066075 (1962-11-01), Deutsch
patent: 3952097 (1976-04-01), Levy
Matsuo et al., Bull. Chem. Soc. Japan, 39, 347-352 (1966).
The United States of America as represented by the Secretary of
Torrence Dolph H.
LandOfFree
Nuclease-resistant hydrophilic complex of polyriboinosinic-polyr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nuclease-resistant hydrophilic complex of polyriboinosinic-polyr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nuclease-resistant hydrophilic complex of polyriboinosinic-polyr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1835004